Schrödinger raises $85M in series E round

Computational physics company Schrödinger LLC (New York, N.Y.) raised $85 million on Jan. 4 in an untranched series E round co-led by existing investor The Bill and Melinda Gates Foundation Trust and the corporate venture fund of WuXi AppTec Co. Ltd. (Shanghai:603259), a new investor. The funds will go towards developing Schrödinger partnered and proprietary programs.

Schrödinger has computational modeling deals with multiple biopharma companies including Nimbus Therapeutics LLC (Cambridge, Mass.), Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Ono Pharmaceutical Co. Ltd. (Tokyo:4528) and Sanofi (Euronext:SAN; NASDAQ:SNY)...